NEJM Interviews

A podcast by NEJM Group - Mercoledì

864 Episodio

NEJM Interview: Dr. H. Gilbert Welch on trends in the incidence of metastatic cancers and their implications for both screening and our understanding of cancer.
Pubblicato: 28/10/2015
NEJM Interview: Dr. Kevin Schulman on the recent approval of two PCSK9 inhibitors and what their prices could mean for insurance premiums.
Pubblicato: 21/10/2015
NEJM Interview: Drs. Allan Goroll and Ateev Mehrotra on whether the annual physical should be retained, eliminated, or modified for 21st-century realities.
Pubblicato: 14/10/2015
NEJM Interview: Dr. David Urbach on a plan to concentrate certain surgical procedures among the physicians and hospitals that perform the most of them.
Pubblicato: 07/10/2015
NEJM Interview: Dr. Michael Fiore on the potential for regulation of nicotine levels in cigarettes to help smokers quit.
Pubblicato: 30/09/2015
NEJM Interview: Dr. Jonathan Oberlander on the outlook for Medicare’s new physician payment system.
Pubblicato: 23/09/2015
NEJM Interview: Dr. Christopher Robertson on the FDA’s new draft guidelines on direct-to-consumer pharmaceutical advertising.
Pubblicato: 16/09/2015
NEJM Interview: Dr. Hermes Taylor-Weiner on the regulation of stem-cell clinics offering unproven therapies.
Pubblicato: 09/09/2015
NEJM Interview: Dr. Georgina Peacock on improvements in care and access to services for people with disabilities and where more work is needed.
Pubblicato: 02/09/2015
NEJM Interview: Dr. Michelle Mello on a new California law that eliminates religious and philosophical exemptions for vaccination mandates.
Pubblicato: 26/08/2015
NEJM Interview: Dr. Philip Landrigan on health concerns associated with genetically modified crops and the herbicides used on them.
Pubblicato: 19/08/2015
NEJM Interview: Dr. David Asch on strategies for testing new ideas in health care quickly and efficiently.
Pubblicato: 12/08/2015
NEJM Interview: Dr. Ronald Bayer on why the heightened focus on precision medicine misses the point when it comes to public health.
Pubblicato: 05/08/2015
NEJM Interview: Dr. Steffanie Strathdee on needle-exchange policies and the recent HIV outbreak in rural Indiana.
Pubblicato: 29/07/2015
NEJM Interview: Dr. Stanley Plotkin on a strategy for stimulating and supporting global vaccine research.
Pubblicato: 22/07/2015
NEJM Interview: Prof. Amy Kapczynski on provisions in the Trans-Pacific Partnership that could affect access to drugs in the United States and abroad.
Pubblicato: 15/07/2015
NEJM Interview: Dr. Joshua Sharfstein on the process of approving new sunscreen ingredients for marketing in the United States.
Pubblicato: 08/07/2015
NEJM Interview: Prof. Ted Kaptchuk on the outlook for harnessing the benefits of placebo effects in medicine.
Pubblicato: 01/07/2015
NEJM Interview: Dr. Jerry Avorn on the 21st Century Cures Act’s potential implications for drug development and safety.
Pubblicato: 24/06/2015
NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to the market.
Pubblicato: 17/06/2015

35 / 44

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Visit the podcast's native language site

864 Episodio

NEJM Interview: Dr. H. Gilbert Welch on trends in the incidence of metastatic cancers and their implications for both screening and our understanding of cancer.

NEJM Interview: Dr. Kevin Schulman on the recent approval of two PCSK9 inhibitors and what their prices could mean for insurance premiums.

NEJM Interview: Drs. Allan Goroll and Ateev Mehrotra on whether the annual physical should be retained, eliminated, or modified for 21st-century realities.

NEJM Interview: Dr. David Urbach on a plan to concentrate certain surgical procedures among the physicians and hospitals that perform the most of them.

NEJM Interview: Dr. Michael Fiore on the potential for regulation of nicotine levels in cigarettes to help smokers quit.

NEJM Interview: Dr. Jonathan Oberlander on the outlook for Medicare’s new physician payment system.

NEJM Interview: Dr. Christopher Robertson on the FDA’s new draft guidelines on direct-to-consumer pharmaceutical advertising.

NEJM Interview: Dr. Hermes Taylor-Weiner on the regulation of stem-cell clinics offering unproven therapies.

NEJM Interview: Dr. Georgina Peacock on improvements in care and access to services for people with disabilities and where more work is needed.

NEJM Interview: Dr. Michelle Mello on a new California law that eliminates religious and philosophical exemptions for vaccination mandates.

NEJM Interview: Dr. Philip Landrigan on health concerns associated with genetically modified crops and the herbicides used on them.

NEJM Interview: Dr. David Asch on strategies for testing new ideas in health care quickly and efficiently.

NEJM Interview: Dr. Ronald Bayer on why the heightened focus on precision medicine misses the point when it comes to public health.

NEJM Interview: Dr. Steffanie Strathdee on needle-exchange policies and the recent HIV outbreak in rural Indiana.

NEJM Interview: Dr. Stanley Plotkin on a strategy for stimulating and supporting global vaccine research.

NEJM Interview: Prof. Amy Kapczynski on provisions in the Trans-Pacific Partnership that could affect access to drugs in the United States and abroad.

NEJM Interview: Dr. Joshua Sharfstein on the process of approving new sunscreen ingredients for marketing in the United States.

NEJM Interview: Prof. Ted Kaptchuk on the outlook for harnessing the benefits of placebo effects in medicine.

NEJM Interview: Dr. Jerry Avorn on the 21st Century Cures Act’s potential implications for drug development and safety.

NEJM Interview: Dr. Aaron Kesselheim on the challenges of bringing follow-on biologic drugs to the market.